Jianfei Qian

6.6k total citations · 3 hit papers
75 papers, 5.0k citations indexed

About

Jianfei Qian is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Jianfei Qian has authored 75 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Immunology, 32 papers in Molecular Biology and 29 papers in Oncology. Recurrent topics in Jianfei Qian's work include Immunotherapy and Immune Responses (33 papers), Multiple Myeloma Research and Treatments (23 papers) and T-cell and B-cell Immunology (17 papers). Jianfei Qian is often cited by papers focused on Immunotherapy and Immune Responses (33 papers), Multiple Myeloma Research and Treatments (23 papers) and T-cell and B-cell Immunology (17 papers). Jianfei Qian collaborates with scholars based in United States, China and Australia. Jianfei Qian's co-authors include Qing Yi, Enguang Bi, Xingzhe Ma, Maojie Yang, Jing Yang, Lintao Liu, Yuhuan Zheng, Qiang Wang, Yong Lu and Sungyoul Hong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Jianfei Qian

72 papers receiving 5.0k citations

Hit Papers

3 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

2019 697 citations Xingzhe Ma, Enguang Bi et al. Cell Metabolism profile →
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability

2021 664 citations Xingzhe Ma, Liuling Xiao et al. Cell Metabolism profile →
Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages

2020 360 citations Pan Su, Qiang Wang et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jianfei Qian United States	37	2.5k	2.0k	1.9k	1.2k	694	75	5.0k
Yulia Nefedova United States	29	3.9k 1.5×	1.9k 1.0×	2.2k 1.2×	557 0.5×	558 0.8×	53	5.7k
Sorena Nadaf United States	20	3.7k 1.4×	2.7k 1.4×	3.2k 1.7×	884 0.7×	208 0.3×	26	6.5k
Ian Kasman United States	20	2.1k 0.8×	2.5k 1.3×	1.5k 0.8×	1.0k 0.9×	175 0.3×	26	5.3k
Anjali Mishra United States	26	1.4k 0.6×	966 0.5×	1.7k 0.9×	473 0.4×	491 0.7×	98	3.5k
Maria Vincenza Carriero Italy	34	951 0.4×	1.5k 0.8×	1.3k 0.7×	1.4k 1.1×	402 0.6×	76	3.8k
Masayuki Miyake Japan	41	962 0.4×	2.2k 1.1×	1.8k 1.0×	676 0.6×	483 0.7×	79	4.4k
Hidayatullah G. Munshi United States	45	803 0.3×	2.3k 1.2×	2.5k 1.4×	1.1k 0.9×	302 0.4×	106	4.8k
Lukas J.A.C. Hawinkels Netherlands	31	1.6k 0.6×	1.9k 0.9×	2.1k 1.1×	895 0.7×	129 0.2×	99	4.8k
Colette Adida France	21	1.0k 0.4×	3.6k 1.8×	1.8k 1.0×	750 0.6×	411 0.6×	24	5.2k
Stefania Bellone United States	41	1.4k 0.5×	1.8k 0.9×	2.4k 1.3×	761 0.6×	141 0.2×	155	5.4k

Countries citing papers authored by Jianfei Qian

Since Specialization

Citations

This map shows the geographic impact of Jianfei Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfei Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfei Qian more than expected).

Fields of papers citing papers by Jianfei Qian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianfei Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfei Qian. The network helps show where Jianfei Qian may publish in the future.

Co-authorship network of co-authors of Jianfei Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Jianfei Qian. A scholar is included among the top collaborators of Jianfei Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianfei Qian. Jianfei Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Chuanchao, Qiang Wang, Pan Su, et al.. (2025). NPC1 as a novel therapeutic target for induction of pyroptosis in cancers. Biomarker Research. 13(1). 115–115.

Xian, Miao, Qiang Wang, Liuling Xiao, et al.. (2024). Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature Communications. 15(1). 5767–5767. 15 indexed citations

Wang, Qiang, Zhijuan Lin, Zhuo Wang, et al.. (2021). RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway. Blood. 139(1). 59–72. 16 indexed citations

Su, Pan, Qiang Wang, Enguang Bi, et al.. (2020). Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages. Cancer Research. 80(7). 1438–1450. 360 indexed citations breakdown →

Ma, Xingzhe, Enguang Bi, Yong Lu, et al.. (2019). Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment. Cell Metabolism. 30(1). 143–156.e5. 697 indexed citations breakdown →

Ma, Xingzhe, Enguang Bi, Chunjian Huang, et al.. (2018). Cholesterol negatively regulates IL-9–producing CD8+ T cell differentiation and antitumor activity. The Journal of Experimental Medicine. 215(6). 1555–1569. 118 indexed citations

Lu, Yong, Qiang Wang, Gang Xue, et al.. (2018). Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors. Cancer Cell. 33(6). 1048–1060.e7. 121 indexed citations

Hong, Bangxing, Haiyan Li, Yong Lu, et al.. (2014). USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity. Molecular Cancer. 13(1). 132–132. 37 indexed citations

Zheng, Yuhuan, Qiang Wang, Jianfei Qian, et al.. (2014). Macrophage Migration Inhibitory Factor Regulates Multiple Myeloma Bone Marrow Homing. Blood. 124(21). 2015–2015. 1 indexed citations

10.

Li, Rong, Jianfei Qian, Wenhao Zhang, et al.. (2014). Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma. British Journal of Haematology. 166(5). 690–701. 29 indexed citations

11.

Liu, Zhiqiang, Jingda Xu, Jin He, et al.. (2014). A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance. Blood. 124(13). 2061–2071. 80 indexed citations

12.

Zhang, Liang, Lan V. Pham, Kate J. Newberry, et al.. (2013). In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome. Molecular Cancer Therapeutics. 12(11). 2494–2504. 22 indexed citations

13.

He, Jin, Zhiqiang Liu, Yuhuan Zheng, et al.. (2012). p38 MAPK in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction. Cancer Research. 72(24). 6393–6402. 69 indexed citations

14.

Zhang, Liang, Jing Yang, Jianfei Qian, et al.. (2012). Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells. Blood. 120(18). 3783–3792. 88 indexed citations

15.

Qian, Jianfei & Qing Yi. (2012). DKK1 as a novel target for myeloma immunotherapy. OncoImmunology. 1(5). 756–758. 9 indexed citations

16.

Zheng, Yuhuan, Jing Yang, Jianfei Qian, et al.. (2011). P/E Selectins and Their Ligand PSGL-1 Are Crucial for Macrophage-Mediated Multiple Myeloma Chemoresistance. Blood. 118(21). 130–130. 2 indexed citations

17.

Yi, Qing, Susann Szmania, John J. Freeman, et al.. (2010). Optimizing dendritic cell‐based immunotherapy in multiple myeloma: intranodal injections of idiotype‐pulsed CD40 ligand‐matured vaccines led to induction of type‐1 and cytotoxic T‐cell immune responses in patients. British Journal of Haematology. 150(5). 554–564. 50 indexed citations

18.

Yang, Jing, Michele Wezeman, Xiang Zhang, et al.. (2007). Human C-Reactive Protein Binds Activating Fcγ Receptors and Protects Myeloma Tumor Cells from Apoptosis. Cancer Cell. 12(3). 252–265. 97 indexed citations

19.

Yang, Jing, Jianfei Qian, Michele Wezeman, et al.. (2006). Targeting β2-microglobulin for induction of tumor apoptosis in human hematological malignancies. Cancer Cell. 10(4). 295–307. 81 indexed citations

20.

Xie, Jin, et al.. (2003). Novel and Detrimental Effects of Lipopolysaccharide on In Vitro Generation of Immature Dendritic Cells: Involvement of Mitogen-Activated Protein Kinase p38. The Journal of Immunology. 171(9). 4792–4800. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact